Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.05

€2.05

0.250%
0.005
0.250%
-

-

 
10.05.21 / Stuttgart Stock Exchange WKN: A14SVV / Name: Sensorion SA / Stock / Biotechnology & Medical Research / Micro Cap /
Latest predictions
-
29.10.20
Your prediction

Sensorion SA Stock

Sensorion SA gained 0.250% compared to yesterday.
The community is currently still undecided about Sensorion SA with 0 Buy predictions and 1 Sell predictions.

Pros and Cons of Sensorion SA in the next few years

Pros
?
Growth compared to competition
?
Brand
?
Worthwhile Investment for the next years
Cons
?
Shareholder structure
?
Market Position
?
Conscious of the environment
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Sensorion SA vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Sensorion SA 0.250% -9.713% -13.531% 151.847% 38.644% - -
Genomic Vision S.A. -0.150% 20.337% 20.482% 8.992% 3.093% -51.515% -90.012%
Genoway S.A. Inh. 6.240% 16.947% 1.592% 30.272% 19.315% 127.976% 146.144%
Neovacs - 16.667% -61.111% -81.579% -54.839% -98.066% -99.388%

Other discussions about Sensorion SA Stock

New thread Forum

News

Sensorion to Attend Three Conferences in May 2021 Including ASGCT to Present a Poster and Co-Chair a Scientific Session


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Sensorion Hosting Key Opinion Leader Webinar with Dr. Thomas Lenarz on the GJB2 Gene Related Hearing Loss on May 10, 2021


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Sensorion Announces That a General Meeting of Shareholders Will Be Held Behind Closed Doors on May 18, 2021 Alongside the Publication of Its 2020 Annual Financial Report


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within